Stay updated with breaking news from Apa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New literature review data suggests doxazosin is related to less incident hypotension than prazosin, while providing clinical benefit, in PTSD patients with condition-related nightmares.
Kane explains why newer long-acting injectables and clozapine may be under-utilized still in the management of schizophrenia.
Marmar explains what anticipated blood and molecular profiling of PTSD may provide psychiatrists treating patients.
Devanand reviews lecanemab and the advent of blood biomarkers for dementia and Alzheimer's management at APA 2024.
APA (NASDAQ:APA – Free Report) had its price objective decreased by Barclays from $40.00 to $38.00 in a research note released on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. Other equities analysts also recently issued reports about the stock. Morgan Stanley restated an underweight rating and set a […]